TTrialPathMatch Me to Trials
← Back to trials
RecruitingCancerProton Therapy

HUmanitas PROtontherapy (HU-PRO)

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Proton therapy is a cancer treatment, similar to the more commonly used radiation therapy. It uses radiation to destroy cancer cells and helps control the disease in the treated area. However, when proton therapy is compared with standard radiation therapy, many studies show fewer side effects and better disease control. This is due to the unique physical properties of the particles used in proton therapy. At present, in Italy, this innovative treatment is available only for selected diseases, as defined by national guidelines. For this reason, it is very important to collect as much data as possible to support the further development of proton therapy and to improve treatment safety and effectiveness.

Sponsor: Istituto Clinico Humanitas

You may qualify if…

  • Solid tumors candidate to proton therapy, in particular, according to Italian regolamentations
  • Written informed consent for HU-PRO according to applicable legal and ethical requirements
  • Indication for proton therapy
  • ≥ 18 years old
  • ECOG PS (performance status scale) 0-2

You may not qualify if…

  • Age \< 18 years old
  • ECOG (performance status scale) \>3
  • Life expectancy \< 3 months
  • Inability to provide informed consent

Where it's recruiting

Michigan

Rozzano

Source: ClinicalTrials.gov · NCT07317245 · last updated 2026-01-21

HUmanitas PROtontherapy (HU-PRO) · TrialPath